吉林男科医院专家预约吉林手术治疗阴茎短小的医院,吉林治疗性疾病最好的男科医院,吉林那里割包皮包茎较好,吉林前列腺囊肿影响性生活吗,吉林做包皮包茎去那家医院好,吉林男性包皮过长该如何治疗,吉林医院睾丸坠胀是怎么回事

UNITED NATIONS, April 7 (Xinhua) -- To celebrate the 50th anniversary of the first human space flight, accomplished on April 12, 1961 by Soviet cosmonaut Yuri Gagarin, the Russian Permanent Mission to the United Nations, the Russian Federal Space Agency and the ITAR-TASS information agency organized an exhibition which was opened here on Thursday."The first human space flight is not one of the most significant events of the past century, but of human history in general," Vitaly Churkin, the Russian permanent representative to the UN, said at the opening ceremony."It's a symbol of courage, thirst for knowledge, and progress," Churkin said.The exhibition contained archival photos telling the story of the first human space flight and of those who made it possible, and historic pictures of Gagarin.As part of the celebration of human space flight's 50th anniversary the UN Postal Administration designed postal stamps which will be issued on April 12, to tell the story of progress that humankind has made beyond earth's boundaries, as Kiyo Akasaka, Under-Secretary-General for Communications and Public Information put it."Fifty years have passed since that amazing voyage, but the legend of Gagarin's courage and journey to the 'final frontier' continues to be a source of inspiration for space exploration for peoples and nations around the world," Akasaka said at the opening of the exhibition.According to Akasaka, the exhibition "sparks people's imagination about what is possible through the peaceful use and exploration of outer space."Other attendees included Russian cosmonaut Oleg Kotov.Gagarin, also known as the Columbus of the Cosmos, traveled into outer space on the height of the Cold War when the Berlin Wall was built, at a moment when it was hardly impossible to imagine that more than 15 nations would work together in humanity' s permanent space outpost -- the International Space Station.The Russian icon of space spoke the historic words "the earth is blue, how wonderful. It is amazing."On Thursday the UN General Assembly adopted a resolution declaring April 12 as the International Day of Human Space Flight.

WASHINGTON, May 20 (Xinhua) -- The U.S. Food and Drug Administration (FDA) on Friday approved Sutent to treat patients with progressive neuroendocrine cancerous tumors located in the pancreas that cannot be removed by surgery or that have spread to other parts of the body.Neuroendocrine tumors found in the pancreas are slow-growing and rare. It is estimated that there are fewer than 1,000 new cases in the United States each year.This is the second new approval by the FDA to treat patients with this disease. On May 5, the agency approved Afinitor."FDA believes it is important to provide cancer patients with as many treatment options as possible," said Richard Pazdur, director of the Office of Oncology Drug Products in the FDA's Center for Drug Evaluation and Research. "The agency is committed to working with companies to bring innovative new therapies to the market and encourages companies to continue exploring additional uses for approved products."The safety and effectiveness of Sutent was established in a single study of 171 patients with metastatic (late-stage) or locally advanced (disease that could not be removed with surgery) disease who received Sutent or a placebo (sugar pill). The study was designed to measure the length of time a patient lived before their disease spread or worsened (progression-free survival).Results from the study demonstrate that Sutent provided benefit to patients by prolonging the median length of time they lived without the cancer spreading or worsening to 10.2 months compared to 5.4 months for patients who received placebo.In patients treated with Sutent for neuroendocrine pancreatic tumors, the most commonly reported side effects included diarrhea, nausea, vomiting, fatigue, anorexia, high blood pressure, energy loss, stomach pain, changes in hair color, inflammation of the mouth, and a decrease in infection-fighting white blood cells.Sutent is marketed by New York City-based Pfizer.

WASHINGTON, April 5 (Xinhua) -- NASA and co-researchers from the United States, the Republic of Korea and Japan have found a new mineral named "Wassonite" in one of the most historically significant meteorites recovered in Antarctica in December 1969, the U.S. space agency said on Tuesday in a statement.The new mineral was discovered within the meteorite officially designated Yamato 691 enstatite chondrite. The meteorite likely may have originated from an asteroid orbiting between Mars and Jupiter. Wassonite is among the tiniest, yet most important, minerals identified in the 4.5-billion-year-old sample.The research team, headed by NASA space scientist Keiko Nakamura-Messenger, added the mineral to the list of 4,500 officially approved by the International Mineralogical Association."Wassonite is a mineral formed from only two elements, sulfur and titanium, yet it possesses a unique crystal structure that has not been previously observed in nature," said Nakamura-Messenger.In 1969, members of the Japanese Antarctic Research Expedition discovered nine meteorites on the blue ice field of the Yamato Mountains in Antarctica. This was the first significant recovery of Antarctic meteorites and represented samples of several different types.As a result, the United States and Japan conducted systematic follow-up searches for meteorites in Antarctica that recovered more than 40,000 specimens, including extremely rare Martian and lunar meteorites.Researchers found Wassonite surrounded by additional unknown minerals that are being investigated. The mineral is less than one-hundredth the width of a human hair or 50x450 nanometers. It would have been impossible to discover without NASA's transmission electron microscope, which is capable of isolating the Wassonite grains and determining their chemical composition and atomic structure."More secrets of the universe can be revealed from these specimens using 21st century nano-technology," said Nakamura- Messenger.The new mineral's name was approved by the International Mineralogical Association. It honors John T. Wasson, professor at the University of California, Los Angeles. Wasson is known for his achievements across a broad swath of meteorite and impact research, including the use of neutron activation data to classify meteorites and to formulate models for the chemical makeup of bulk chondrites.

HOUSTON, April 15 (Xinhua) -- A major contractor for the U.S. space shuttle on Friday announced plans to lay off about 50 percent of its employees this summer after NASA retires the orbiter fleet.The contractor, Houston-based United Space Alliance, said it will cut 2,600 to 2,800 jobs, including 1,850 to 1,950 employees in Florida, 750 to 800 employees in Texas, and 30 to 40 employees in Alabama, "due to the completion of tasks related to day-to-day operations of the Shuttle fleet."The cuts will be made in late July and early August after NASA completes the final flight of Endeavour, scheduled for April 29, and the flight of Atlantis on June 28."The accomplishments of this team are unmatched in human spaceflight," Virginia Barnes, the company's president, said in a news release. "It will be difficult to say goodbye to such tremendously talented and dedicated teammates, and we are committed to making this transition as smooth as possible for them."United Space Alliance has approximately 5,600 employees working at sites in Texas, Florida and Alabama, according to the the news release.

WASHINGTON, March 30 (Xinhua) -- A trace amount of radioactive iodine has been found in a sample of milk from the west state of Washington, the U.S. Environmental Protection Agency and the Food and Drug Administration (FDA) said Wednesday.According to a joint statement from the two agencies, results from a screening sample taken March 25 from Washington detected 0.8 pCi/L of iodine-131, which is more than 5,000 times lower than the Derived Intervention Level set by the FDA.These types of findings are to be expected in the coming days and are far below levels of public health concern, including for infants and children, the statement said.Iodine-131 has a very short half-life of approximately eight days, and the level detected in milk and milk products is therefore expected to drop relatively quickly."Radiation is all around us in our daily lives, and these findings are a minuscule amount compared to what people experience every day. For example, a person would be exposed to low levels of radiation on a round trip cross country flight, watching television, and even from construction materials," said Patricia Hansen, an FDA senior scientist.